GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Handa Pharmaceuticals Inc (ROCO:6620) » Definitions » Scaled Net Operating Assets

Handa Pharmaceuticals (ROCO:6620) Scaled Net Operating Assets : 0.13 (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Handa Pharmaceuticals Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Handa Pharmaceuticals's operating assets for the quarter that ended in Jun. 2024 was NT$614.9 Mil. Handa Pharmaceuticals's operating liabilities for the quarter that ended in Jun. 2024 was NT$207.8 Mil. Handa Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2024 was NT$3,244.5 Mil. Therefore, Handa Pharmaceuticals's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.13.


Handa Pharmaceuticals Scaled Net Operating Assets Historical Data

The historical data trend for Handa Pharmaceuticals's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Handa Pharmaceuticals Scaled Net Operating Assets Chart

Handa Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.27 0.31 0.77 0.57

Handa Pharmaceuticals Quarterly Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.42 0.16 0.04 0.13

Competitive Comparison of Handa Pharmaceuticals's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Handa Pharmaceuticals's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Handa Pharmaceuticals's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Handa Pharmaceuticals's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Handa Pharmaceuticals's Scaled Net Operating Assets falls into.


;
;

Handa Pharmaceuticals Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Handa Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(717.704-267.641)/790.564
=0.57

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3037.19 - 2319.486
=717.704

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=280.881 - 7.671 - 5.569
=267.641

Handa Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jun. 2024 )
=(Operating Assets (Q: Jun. 2024 )-Operating Liabilities (Q: Jun. 2024 ))/Total Assets (Q: Mar. 2024 )
=(614.946-207.813)/3244.499
=0.13

where

Operating Assets(Q: Jun. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3145.94 - 2530.994
=614.946

Operating Liabilities(Q: Jun. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=244.704 - 31.153 - 5.738
=207.813

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Handa Pharmaceuticals Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Handa Pharmaceuticals's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Handa Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Nanke 3rd Road, 3F-1,3F-2, No.23, Xinshi Dist, Tainan, TWN, 74147
Handa Pharmaceuticals Inc is a Taiwan-based specialty pharmaceutical company. It is engaged in the development of niche drugs. The company focuses on the development of high-barrier/patentable niche products.

Handa Pharmaceuticals Headlines

No Headlines